Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study

Auteurs

H.S. Han, V. Diéras, M. Robson, M. Palácová, P.K. Marcom, A. Jager, I. Bondarenko, D. Citrin, M. Campone, M.L. Telli, S.M. Domchek, M. Friedlander, B. Kaufman, J.E. Garber, Y. Shparyk, E. Chmielowska, E.H. Jakobsen, V. Kaklamani, W. Gradishar, C.K. Ratajczak, C. Nickner, Q. Qin, J. Qian, S.P. Shepherd, S.J. Isakoff, S. Puhalla